Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience

被引:0
作者
Weglarz, Przemyslaw [1 ]
Konarska-Kuszewska, Ewa [1 ]
Spisak-Borowska, Katarzyna [2 ]
Machowski, Jerzy [2 ]
Drzewiecka-Gerber, Agnieszka [1 ]
Kuszewski, Piotr
Jackson, Christopher L. [4 ]
Opala, Grzegorz [3 ]
Trusz-Gluza, Maria [1 ]
机构
[1] Med Univ Silesia, Dept Cardiol 1, PL-40635 Katowice, Poland
[2] Dept Neurol, Oswiecim, Poland
[3] Med Univ Silesia, Dept Neurol, PL-40635 Katowice, Poland
[4] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England
关键词
patent foramen ovale; PFO; complications; closure procedures; PARADOXICAL EMBOLISM; TRANSCATHETER CLOSURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; THROMBOEMBOLIC EVENTS; THROMBUS FORMATION; MEDICAL THERAPY; PFO OCCLUDER; FOLLOW-UP; STROKE; DEVICES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patent foramen ovale (PFO) is a potential risk factor for ischaemic stroke in young individuals. An interventional method of secondary stroke prevention in PFO patients is its percutaneous closure. Aim: To assess safety and effectiveness (i.e. lack of residual shunt) of percutaneous PFO closure in patients with history of cryptogenic cerebrovascular event. Methods: 149 patients (56 men/93 women), aged 39 +/- 12 years, underwent percutaneous PFO closure. The implantation was performed under local anaesthesia, guided by trans-oesophageal echocardiography (TEE) and fluoroscopy. Follow-up trans-thoracic echocardiography (TTE) was performed at 1 month and follow-up TEE at 6-months. In cases of residual shunt, additional TEE was performed after ensuing 6 months. Results: Effective PFO closure (no residual shunt) was achieved in 91.3% patients at 6 months and 95.3% patients at 12 months. In 2 patients transient atrial fibrillation was observed during the procedure. In 2 patients, a puncture site haematoma developed and in 1 patient superficial thrombophlebitis was noted. In 1 patient a small pericardial effusion was observed, which resolved at day 3 post-procedurally, after administration of non-steroidal anti-inflammatory drugs. Conclusions: Percutaneous PFO closure seems to be a safe procedure when performed in a centre with adequate expertise with regard to these procedures.
引用
收藏
页码:478 / 485
页数:8
相关论文
共 21 条
[1]   Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices [J].
Anzai, H ;
Child, J ;
Natterson, B ;
Krivokapich, J ;
Fishbein, MC ;
Chan, VK ;
Tobis, JM .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04) :426-431
[2]   Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices [J].
Bissessor, Naylin ;
Wong, Allison W. ;
Hourigan, Lisa A. ;
Jayasinghe, Rohan S. ;
Scalia, Greg S. ;
Burstow, Darryl J. ;
Griffiths, Lyn R. ;
Savage, Michael ;
Walters, Darren L. .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2011, 12 (03) :164-169
[3]   Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism - Periprocedural safety and mid-term follow-up results of three different device occluder systems [J].
Braun, M ;
Gliech, V ;
Boscheri, A ;
Schoen, S ;
Gahn, G ;
Reichmann, H ;
Haass, M ;
Schraeder, R ;
Strasser, RH .
EUROPEAN HEART JOURNAL, 2004, 25 (05) :424-430
[4]   Transcatheter closure of patent foramen ovale in patients with cerebral ischemia [J].
Braun, MU ;
Fassbender, D ;
Schoen, SP ;
Haass, M ;
Schraeder, R ;
Scholtz, W ;
Strasser, RH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) :2019-2025
[5]   Management of Residual Shunts After Initial Percutaneous Patent Foramen Ovale Closure: A Single Center Experience With Immediate and Long-Term Follow-Up [J].
Diaz, Tulio ;
Cubeddu, Roberto J. ;
Rengifo-Moreno, Pablo A. ;
Cruz-Gonzalez, Ignacio ;
Solis-Martin, Jorge ;
Buonanno, Ferdinando S. ;
Inglessis, Ignacio ;
Palacios, Igor F. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (01) :145-150
[6]   Study Design of the CLOSURE I Trial A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale [J].
Furlan, Anthony J. ;
Reisman, Mark ;
Massaro, Joseph ;
Mauri, Laura ;
Adams, Harold ;
Albers, Gregory W. ;
Felberg, Robert ;
Herrmann, Howard ;
Kar, Saibal ;
Landzberg, Michael ;
Raizner, Albert ;
Wechsler, Lawrence .
STROKE, 2010, 41 (12) :2872-2883
[7]   DIAGNOSIS OF PATENT FORAMEN OVALE BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY AND ASSOCIATION WITH CEREBRAL AND PERIPHERAL EMBOLIC EVENTS [J].
HAUSMANN, D ;
MUGGE, A ;
BECHT, I ;
DANIEL, WG .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (06) :668-672
[8]   Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli - A systematic review [J].
Khairy, P ;
O'Donnell, CP ;
Landzberg, MJ .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (09) :753-760
[9]   Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients [J].
Krumsdorf, U ;
Ostermayer, S ;
Billinger, K ;
Trepels, T ;
Zadan, E ;
Horvath, K ;
Sievert, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (02) :302-309
[10]   Etiologic investigation of ischemic stroke in young adults [J].
Larrue, V. ;
Berhoune, N. ;
Massabuau, P. ;
Calviere, L. ;
Raposo, N. ;
Viguier, A. ;
Nasr, N. .
NEUROLOGY, 2011, 76 (23) :1983-1988